Pilonidal sinus treatment studying the options: trial of pit-picking plus fibrin glue vs other minimally invasive surgeries

ISRCTN ISRCTN13560209
DOI https://doi.org/10.1186/ISRCTN13560209
Integrated Research Application System (IRAS) 357963
Central Portfolio Management System (CPMS) 68155
National Institute for Health and Care Research (NIHR) 175072
Sponsor Sheffield Teaching Hospitals NHS Foundation Trust
Funder National Institute for Health and Care Research
Submission date
30/09/2026
Registration date
01/10/2026
Last edited
01/10/2026
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Skin and Connective Tissue Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Pilonidal sinus disease (PSD) is a condition that usually affects the skin just at the top of the buttocks near the tailbone. It is a chronic condition characterised by a small hole, sinus, or cyst that develops in the skin and often becomes infected. Infection will cause pain and swelling in the area and a pus-filled skin abscess can develop.
The cure for PSD usually requires surgery, with two main surgical approaches. One involves removing the affected skin and closing the wound, the other aims to save the skin by using so-called minimally invasive surgery (MIS). The PITSTOP study concluded that the burden after surgery for PSD is high and treatment failure common. MIS may improve outcomes at the expense of a 10% higher risk of treatment failure. The most appropriate treatment depends on the type and severity of a patient’s disease, but for those patients who are suitable for MIS, there are several different techniques that can be used.
At the moment, we do not know whether one MIS is better than the other; PITSTOP found that ‘Pit picking + glue’ is the most common MIS in the UK. In this trial we will compare this technique to other MIS procedures used as standard of care within the UK NHS.

Who can participate?
Patients aged 16 years and over who are undergoing MIS for PSD

What does the study involve?
Participants will be randomly assigned to have either the pit-picking plus glue or whatever other type of operation that the surgeon thinks is best. The patient will not know which surgery they have had. After their surgery, each patient will be followed up at numerous time points, up to 1 year after surgery, to see how they are recovering.

What are the possible benefits and risks of participating?
Not provided at time of registration

Where is the study run from?
Sheffield Teaching Hospitals NHS Foundation Trust (UK)

When is the study starting and how long is it expected to run for?
September 2026 to February 2030

Who is funding the study?
National Institute for Health and Care Research (NIHR) (UK)

Who is the main contact?
1. Prof. Steven Brown, steven.brown13@nhs.net
2. Ms Gemma Hackney, PITSTOP2@sheffield.ac.uk

Contact information

Prof Steven Brown
Principal investigator, Scientific

Northern General Hospital
Herries Road
Sheffield
S5 7AU
United Kingdom

Phone +44 (0)114 2434343
Email steven.brown13@nhs.net
Ms Gemma Hackney
Public

Sheffield Centre for Health and Related Research (SCHARR)
School of Medicine and Population Health
The University of Sheffield
Regent Court
30 Regent Street
Sheffield
S1 4DA
United Kingdom

Phone +44 (0)114 222 4320
Email PITSTOP2@sheffield.ac.uk

Study information

Primary study designInterventional
AllocationRandomized controlled trial
MaskingBlinded (masking used)
ControlActive
AssignmentParallel
PurposeTreatment
Scientific titlePilonidal sinus treatment studying the options: trial of pit-picking plus fibrin glue vs other minimally invasive surgeries
Study acronymPITSTOP2
Study objectives 1. To compare whether pit picking + glue results in a significantly faster time to return to normal activities than other minimally invasive interventions for PSD
2. To compare whether pit picking + glue results in a similar treatment failure rate to other minimally invasive interventions for PSD
3. To compare outcomes after stratifying into non-complex (non-recurrent disease with pits or sinuses confined to the midline) and complex disease (midline disease with secondary sinus/es or abscess scar/s or any disease after treatment with definitive intent)
Ethics approval(s)

Approved 29/07/2026, North West - Greater Manchester South Research Ethics Committee (2 Redman Place, Stratford, London, E20 1JQ, United Kingdom; -; gmsouth.rec@hra.nhs.uk), ref: 26/NW/0194

Health condition(s) or problem(s) studiedPilonidal sinus disease (PSD)
InterventionOnce eligibility has been confirmed and consent acquired, the participant will be randomly allocated (in a 1:1 ratio) to one of the following groups: intervention (pit picking + glue) or control (surgeon's choice standard of care MIS - pit picking alone, Bascom’s 1, endoscopic pilonidal sinus treatment [EPSIT] or sinus laser assisted closure [SILAC]) using the Sheffield CTRU online randomisation system.

On the day of surgery, baseline measures will be taken and the participant will undergo their intervention. At Day 1, 7 and 21, participants will be asked to complete follow up questionnaires via telephone assessment or online. The 6-week follow-up visit will be in line with the standard of care post-surgical follow up visit for these participants, and will be completed in clinic. At 6 and 12 months, participants will be asked to complete follow up questionnaires by telephone, online or post. At the 12-month visit, disease recurrence will be evaluated by photograph, participants will have the option of either attending the clinic for an in-person follow-up to assess recurrence (if they prefer) or to remotely take a photo of the pilonidal sinus site and upload it to the database for the trial. Further information will be provided to participants who wish to upload photos remotely.

The trial follows the standard pathway for pilonidal disease surgery. All timepoints for data collection will be carried out either electronically, via post or telephone. There is no need for additional clinical appointments other than standard of care.
Intervention typeOther
Primary outcome measure(s)
  1. Time to return to usual activities after surgery, measured using time to return to pre-illness daily routine without limitation, e.g. return to work or school at pre-illness levels (full/part-time) and/or unrestricted mobility in routine tasks (walking/sitting/stairs) and/or no requirement for regular analgesia beyond paracetamol+/-NSAIDs, reported by the participant.
  2. Treatment failure measured using patient report at 6 months. Participants will be asked whether they consider their pilonidal sinus disease cured or sufficiently better to not require further treatment and whether the same or worse than before surgery. Treatment failure will also be considered to have occurred if the patient has had to have a further procedure within that 6-month period.
Key secondary outcome measure(s)

1. Time over a 12-month period where the patient is unable to do usual activities, measured using participant report
2. Need for further surgery for persistent disease or recurrence by 12 months and end of study, measured using participant report and assessment by colorectal surgeon of disease area
3. Patient-reported treatment failure at 12 months
4. Clinical assessment of recurrence at 12 months and at trial end. Recurrence is defined as disease (midline pits/ulcers +/- lateral extensions) that has healed after surgery and then recurred at the same site or a new position. This will be assessed by a patient photograph of the site or a clinic appointment (participants choice).
5. Length of stay in hospital, measured using participant medical notes
6. Pain measured using participant-reported questionnaire (Numeric Pain Rating Scale) at days 1, 7 and 21
7. Quality of life measured using EQ-5D-5L at baseline
8. Complications (bleeding, infection, wound dehiscence) reported by participant or from participant's medical notes from day of surgery to 6 weeks post-surgery
9. Health-related quality of life measured using the Cardiff Wound Impact Schedule (CWIS) at 6 and 12 months
10. Health-related quality of life measured using the Health Anxiety Inventory (HAI) at 0, 6 and 12 months
11. Patient health and social care resource use and indirect costs (time off work) measured using participant questionnaire at 0, 6 and 12 months
12. Feasibility outcomes of recruitment % completion, recruitment rate, total recruitment and number of sites open for the internal pilot, reported and reviewed by the central trial management team at month 20 (1 year after recruitment starts)

Completion date28/02/2030

Eligibility

Participant type(s)
Age groupMixed
Lower age limit16 Years
Upper age limit100 Years
SexAll
Target sample size at registration610
Key inclusion criteria1. Adult patients over 16 years old
2. Pilonidal sinus disease (including recurrent disease) where elective minimally invasive surgery (MIS) is planned
3. Able to give informed consent
4. Symptomatic pilonidal sinus disease (pain, discharge, bleeding)
Key exclusion criteria1. Acute abscess
2. Hypersensitivity to tissue glue
3. Pregnancy (tested as per routine care)
Date of first enrolment30/10/2026
Date of final enrolment31/12/2028

Locations

Countries of recruitment

  • United Kingdom
  • England
  • Scotland

Study participating centres

Sheffield Teaching Hospitals NHS Foundation Trust
Northern General Hospital
Herries Road
Sheffield
S5 7AU
England
University Hospitals Birmingham NHS Foundation Trust
Queen Elizabeth Hospital
Mindelsohn Way
Edgbaston
Birmingham
B15 2GW
England
Nottingham University Hospitals NHS Trust
Trust Headquarters
Queens Medical Centre
Derby Road
Nottingham
NG7 2UH
England
Chelsea and Westminster Hospital NHS Foundation Trust
Chelsea & Westminster Hospital
369 Fulham Road
London
SW10 9NH
England
University Hospitals of Derby and Burton NHS Foundation Trust
Royal Derby Hospital
Uttoxeter Road
Derby
DE22 3NE
England
Dartford and Gravesham NHS Trust
Darent Valley Hospital
Darenth Wood Road
Dartford
DA2 8DA
England
Bolton NHS Foundation Trust
The Royal Bolton Hospital
Minerva Road
Farnworth
Bolton
BL4 0JR
England
Mersey and West Lancashire Teaching Hospitals NHS Trust
Whiston Hospital
Warrington Road
Prescot
L35 5DR
England
Wirral University Teaching Hospital NHS Foundation Trust
Arrowe Park Hospital
Arrowe Park Road
Upton
Wirral
CH49 5PE
England
Somerset NHS Foundation Trust
Trust Management
Lydeard House
Musgrove Park Hospital
Taunton
TA1 5DA
England
The Newcastle upon Tyne Hospitals NHS Foundation Trust
Freeman Hospital
Freeman Road
High Heaton
Newcastle upon Tyne
NE7 7DN
England
Manchester University NHS Foundation Trust
Cobbett House
Oxford Road
Manchester
M13 9WL
England
Countess of Chester Hospital NHS Foundation Trust
Countess of Chester Health Park
Liverpool Road
Chester
CH2 1UL
England
Cambridge University Hospitals NHS Foundation Trust
Cambridge Biomedical Campus
Hills Road
Cambridge
CB2 0QQ
England
Tameside and Glossop Integrated Care NHS Foundation Trust
Tameside General Hospital
Fountain Street
Ashton-under-lyne
OL6 9RW
England
NHS Lothian
Waverley Gate
2-4 Waterloo Place
Edinburgh
EH1 3EG
Scotland
Sherwood Forest Hospitals NHS Foundation Trust
Mansfield Road
Sutton-in-Ashfield
NG17 4JL
England
South Tyneside and Sunderland NHS Foundation Trust
Sunderland Royal Hospital
Kayll Road
Sunderland
SR4 7TP
England
Cwm Taf Morgannwg University Local Health Board
Dewi Sant Hospital
Albert Road
Pontypridd
CF37 1LB
Wales
NHS Tayside
Ninewells Hospital
Dundee
DD2 1GZ
Scotland
Kettering General Hospital NHS Foundation Trust
Rothwell Road
Kettering
NN16 8UZ
England
London North West University Healthcare NHS Trust
Northwick Park Hospital
Watford Road
Harrow
HA1 3UJ
England
Northern Care Alliance NHS Foundation Trust
Salford Royal
Stott Lane
Salford
M6 8HD
England

Results and Publications

Individual participant data (IPD) Intention to shareNo

Editorial Notes

30/09/2026: Study's existence confirmed by the NIHR.